Mankind Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

40.06

40.06

40.06

40.06

40.06

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

7,743.85

6,028.72

4,694.21

3,611.39

3,024.76

Loan funds

Secured loans

-

687.89

95.00

-

190.00

Unsecured loans

-

-

-

-

-

Total

7,783.91

6,756.67

4,829.27

3,651.45

3,254.82

Uses of funds

Fixed assets

Gross block

3,551.71

3,185.08

1,193.84

1,097.52

880.27

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

409.49

298.56

206.43

152.76

102.36

Net block

3,142.22

2,886.52

987.41

944.76

777.91

Capital work-in-progress

494.78

386.57

165.57

147.62

211.11

Investments

3,102.23

2,148.44

2,396.89

1,783.67

1,698.01

Net current assets

Current assets, loans & advances

2,631.89

2,991.33

2,330.46

1,655.05

1,184.92

Less : current liabilities & provisions

1,587.21

1,656.18

1,051.06

879.65

617.14

Total net current assets

1,044.68

1,335.15

1,279.40

775.39

567.78

Miscellaneous expenses not written

-

-

-

-

-

Total

7,783.91

6,756.67

4,829.27

3,651.45

3,254.82

Notes:

Book value of unquoted investments

2,040.76

1,760.67

2,396.89

1,783.67

1,698.01

Market value of quoted investments

1,061.47

387.77

-

-

-

Contingent liabilities

168.37

275.47

-

-

-

Number of equity sharesoutstanding (Lacs)

4005.88

4005.88

4005.88

4005.88

4005.88